Behind New York's headline cannabis numbers — $3.3 billion in cumulative sales, 600-plus dispensaries — sits a more revealing story in the fine print of the state's own data. The market isn't just growing; it's concentrating. New figures from the Office of Cannabis Management show that the top 10 dispensaries account for roughly 29% of statewide sales, and the top-performing half of stores generate about 80% of total revenue. And one region towers over the rest: Long Island alone makes up about 47% of annualized adult-use sales.
For anyone trying to understand where New York's market is actually heading, those numbers matter more than the topline.
Concentration is a sign of maturity
It's tempting to read "a few stores dominate" as a problem. It isn't — it's a sign the market is growing up. Nearly every retail industry concentrates as it matures: a minority of locations, brands, and operators end up driving a majority of the revenue. Grocery, pharmacy, hardware, coffee — the pattern repeats. Cannabis, having moved past its chaotic launch phase, is now following the same well-worn path.
That the top 10 stores drive 29% of sales, and the top half drive 80%, tells you the market is sorting winners from the rest based on the things that actually matter: location, selection, service, pricing, and execution. The shops that nail those fundamentals are pulling ahead; the ones that don't are getting left behind. That's competition working as intended.
A market where every store performs the same is a market that hasn't matured. New York's data shows real differentiation — the hallmark of a market sorting itself out.
The Long Island phenomenon
The single most striking figure is Long Island's share: roughly 47% of annualized adult-use sales across all ten of New York's regions. Let that sink in — one region accounting for nearly half the state's adult-use sales.
There are real reasons for it. Long Island combines a large, affluent population with comparatively limited early competition and a customer base that embraced the legal market quickly. It's also a region where the gray market had less of a stranglehold than parts of the city, giving licensed operators cleaner air to grow in. The result is a regional powerhouse — and a reminder that New York's cannabis story isn't only a New York City story.
It's no accident that some of the state's most prominent multi-location operators have planted flags on Long Island. The data explains the strategy. You can see how active that market is by browsing licensed dispensaries and the day's cannabis deals across the region on High Today.
What it means for operators
For operators, this data is both a warning and a map. The warning: in a concentrating market, being average isn't enough — the revenue is flowing to the top performers, and the gap between the leaders and the rest is widening. The map: it shows exactly where the demand is (Long Island, and the top-performing stores) and what it rewards (the fundamentals of good retail).
The operators who internalize this will invest accordingly — in the regions and store experiences that actually drive revenue, rather than spreading thin. The ones who don't risk being part of the long tail that splits the remaining 20% of revenue.
What it means for shoppers
For consumers, concentration is mostly a useful signal. The stores rising to the top are doing so by winning on selection, service, and value — the same things you care about as a shopper. Following where the market is voting with its dollars is a reasonable shortcut to finding strong shops. And in a competitive, concentrating market, comparison shopping pays more than ever, because the spread between the best and the rest keeps widening. Comparing the day's deals and brands on High Today is how you make that work for you.
What concentration doesn't tell you
It's worth reading the numbers with some care, because raw concentration data can mislead. A store landing in the top 10 isn't proof it's the "best" shop in any qualitative sense — it may reflect an unbeatable location, a first-mover advantage in a hungry area, or simply being one of the only licensed options in a high-demand region. Long Island's 47% share, for instance, owes as much to demographics and limited early competition as to any single operator's brilliance. Concentration measures revenue, not virtue.
There's an equity dimension to watch, too. A market that concentrates revenue among a top tier can quietly raise the barriers for the small, independent, and equity operators who make up the majority of New York's licenses. If the winners pull further ahead while the long tail splits a shrinking slice, the state's equity-first model could come under strain — which is part of why programs that support smaller operators matter. None of this contradicts the maturation story; it just complicates it. A healthy market concentrates, but a fair one also keeps room for the small operators serving neighborhoods the giants overlook. Watching whether New York can do both — reward its top performers and sustain its long tail — is one of the more important questions the next few years will answer.
The bottom line
New York's cannabis market has graduated from "is it working?" to "who's winning?" — and the data answers clearly. A concentrated top tier drives most of the sales, Long Island is the regional juggernaut, and the gap between leaders and laggards is the unmistakable signature of a maturing industry. None of that is cause for alarm; it's what healthy markets look like as they grow up. The next chapter of New York cannabis won't be written by 600 equal stores — it'll be written by the ones that figure out how to win.